Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

From Christie Hospital, Manchester (J.V.); Hammersmith Hospital, Imperial College Health Care Trust (H.W.), Royal Marsden Hospital (D.C.), Cancer Research United Kingdom and University College London Cancer Trials Centre (S.H., M.R.), Institute of Hepatology, University College London (S.P.P.), and University College London Cancer Institute (J.B.) — all in London; University Hospital Birmingham, Birmingham (D.H.P.); St. James’s Hospital, Leeds (A.A.); Castle Hill Hospital, Hull (A.M.); Nottingham University Hospitals, Nottingham (S.M.); and Southampton University Hospitals, Southampton (T.I.) — all in the United Kingdom. Address reprint requests to Dr. Bridgewater at the University College London Cancer Institute, 72 Huntley St., London WC1E 6AA, United Kingdom, or at [email protected].